Morgan Stanley’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
|
|||||
|
2025
Q1 | $17.3M | Buy |
|
|||||
|
2024
Q4 | $10.4M | Buy |
|
|||||
|
2024
Q3 | $21.2M | Buy |
|
|||||
|
2024
Q2 | $15.3M | Buy |
|
|||||
|
2024
Q1 | $19.1M | Sell |
|
|||||
|
2023
Q4 | $73.6M | Buy |
|
|||||
|
2023
Q3 | $14.3M | Buy |
|
|||||
|
2023
Q2 | $2M | Sell |
|
|||||
|
2023
Q1 | $6.02M | Sell |
|
|||||
|
2022
Q4 | $6.86M | Buy |
|
|||||
|
2022
Q3 | $2.31M | Sell |
|
|||||
|
2022
Q2 | $3.31M | Buy |
|
|||||
|
2022
Q1 | $2.82M | Buy |
|
|||||
|
2021
Q4 | $417K | Sell |
|
|||||
|
2021
Q3 | $3.17M | Buy |
|
|||||
|
2021
Q2 | $976K | Buy |
|
|||||
|
2021
Q1 | $18K | Sell |
|
|||||
|
2020
Q4 | $5.34M | Buy |
|
|||||
|
2020
Q3 | $24K | Sell |
|
|||||
|
2020
Q2 | $81K | Buy |
|